RESP012 - MDI: Aerosol Delivery
This course contains three separate presentations on inhalation aerosol therapy given at the 1998 AARC International Respiratory Congress Symposium. The course is provided courtesy of Philips Respironics' Asthma & Allergy Division.
This course contains three separate presentations on inhalation aerosol therapy given at the 1998 AARC International Respiratory Congress Symposium. The course is provided courtesy of Philips Respironics' Asthma & Allergy Division.
Learning objectives:
- List at least two reasons a patient should use a metered dose inhaler (MDI) with a spacer;
- Explain for which three diseases that bronchodilators are useful;
- Define asthma and the prevalence of the disease throughout the United States;
- Identify the three requirements for inhalation aerosol therapy to be effective;
- Define impaction and diffusion;
- Identify the factors that are critical to the success of inhalation aerosol therapy;
- List the critical design features of spacers;
- Explain the importance of flow rate through a spacer;
- Identify the responsibilities of the National Asthma Education and Prevention Program (NAEPP);
- Identify the steps that asthma patients can take to self-manage their disease.
To successfully complete this course, you must attain a minimum score of 80% on the final exam and complete the course training survey.
Continuing education: 1.0 contact hours by the Commission for Case Manager Certification (CCMC); VGM Education is authorized by IACET to offer 0.4 CEUs for this program.
Language | English |
---|